GSK-3 protein and the heart: friend or foe?
Metabolic syndrome manifesting as obesity, insulin resistance and type 2 diabetes mellitus is currently pandemic. Each of these, in its own right, is strongly related to the development of cardiovascular disease. The cardiomyopathy associated with these disorders is characterised by curtailed glucos...
Enregistré dans:
Auteurs principaux: | B. Huisamen, A. Lochner |
---|---|
Format: | article |
Langue: | EN |
Publié: |
South African Heart Association
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a80b9bebb8ff412ab3e03c2e2ac3c918 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Amniotic fluid exerts a neurotrophic influence on fetal neurodevelopment via the ERK/GSK-3 pathway
par: Jang,Yongwoo, et autres
Publié: (2015) -
Exogenous Albumin Is Crucial for Pig Sperm to Elicit In Vitro Capacitation Whereas Bicarbonate Only Modulates Its Efficiency
par: Bruna Resende Chaves, et autres
Publié: (2021) -
Cerebral Embolic Protection in TAVI: Friend or Foe
par: Michael Teitelbaum, et autres
Publié: (2019) -
Suppressor of Cytokine Signaling 2 Regulates Retinal Pigment Epithelium Metabolism by Enhancing Autophagy
par: Xi-Yuan Liu, et autres
Publié: (2021) -
ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
par: A. S. Kulakova, et autres
Publié: (2021)